Stockley's Drug Interactions

Stockley’s Drug Interactions, edited by Claire L Preston, remains the world’s most comprehensive and authoritative international reference book on drug interactions. Based upon thousands of published papers and reports this eleventh edition:

• Covers interactions between therapeutic drugs, proprietary medicines, herbal medicines, foods, drinks, and drugs of abuse
• Contains in-depth yet concise monographs in an easy-to-read format
• Provides comprehensive details of the clinical evidence for the interactions under discussion, an assessment of their clinical importance, and clear guidance on managing the interaction in practice
• Has a brief summary of the interaction in each monograph – perfect for the busy healthcare professional
• Is fully referenced throughout
• Contains almost 4500 monographs
• Is global in coverage – inclusion of drugs used worldwide

New in the 11th edition: 

• Over 350 new monographs added
• Many existing monographs have been reviewed, revalidated, and updated
• A comprehensive update and restructure of the chapter on Antidiabetic drugs, in-line with published literature
• Addition of new advice regarding the concurrent use of aliskiren, ACE inhibitors, and angiotensin-II receptor antagonists
• An updated list of drugs that have a risk of prolonging the QT interval
• The addition of new drugs, including apixaban, apremilast, dolutegravir, lomitapide, mirabegron, the NS5A inhibitors (daclatasvir, ledipasvir, ombitasvir), the NS5B inhibitors (dasabuvir, sofosbuvir), the sodium-glucose co-transporter-2 inhibitors (canagliflozin, dapagliflozin, empagliflozin), and telavancin